Company Filing History:
Years Active: 2019
Title: Innovations of Li Xing in Medical Research
Introduction
Li Xing is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the use of fibroblast growth factor 2 (FGF-2). His innovative work aims to address critical health issues, including lung injuries and influenza.
Latest Patents
Li Xing holds a patent for the novel use of fibroblast growth factor 2. This invention provides a unique application of FGF-2 in the preparation of medicine. The patent outlines several uses of the medicine, including (a) the prevention and/or treatment of lung injury, (b) the prevention and/or treatment of influenza, and (c) the prevention and/or treatment of diseases caused by influenza viruses.
Career Highlights
Li Xing is affiliated with the Beijing Institute of Microbiology and Epidemiology. His work at this institution has allowed him to focus on groundbreaking research that has the potential to improve public health outcomes.
Collaborations
Li Xing collaborates with notable colleagues, including Xiliang Wang and Chengyu Jiang. Their combined expertise enhances the research efforts at the Beijing Institute of Microbiology and Epidemiology.
Conclusion
Li Xing's innovative contributions to medical research, particularly through his patent on fibroblast growth factor 2, highlight his commitment to advancing healthcare solutions. His work has the potential to make a significant impact on the prevention and treatment of serious health conditions.